BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19125015)

  • 21. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GEP- NETS UPDATE: Genetics of neuroendocrine tumors.
    Crona J; Skogseid B
    Eur J Endocrinol; 2016 Jun; 174(6):R275-90. PubMed ID: 27165966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.
    Turaga KK; Kvols LK
    CA Cancer J Clin; 2011; 61(2):113-32. PubMed ID: 21388967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors.
    Araujo-Castro M
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():63-73. PubMed ID: 36396595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract.
    Oberg K
    Curr Opin Oncol; 1994 Jul; 6(4):441-51. PubMed ID: 7803546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors.
    Burnik FS; Yalçin S
    Chemotherapy; 2009; 55(5):381-5. PubMed ID: 19752553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
    Lindholm DP; Oberg K
    Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Some etiopathogenetic and diagnostic considerations in neuroendocrine tumors, with particular attention to those in urology].
    Alberti C
    Recenti Prog Med; 2011 Jun; 102(6):267-77. PubMed ID: 21779109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary tumours of the endocrine pancreas].
    Igaz P; Igaz I; Rácz K; Tulassay Z
    Orv Hetil; 2006 Feb; 147(5):195-200. PubMed ID: 16509219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
    Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
    Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetics of neuroendocrine tumors].
    Calender A
    Rev Prat; 2002 Feb; 52(3):256-61. PubMed ID: 11925714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary neuroendocrine tumors of the gastroenteropancreatic system.
    Anlauf M; Garbrecht N; Bauersfeld J; Schmitt A; Henopp T; Komminoth P; Heitz PU; Perren A; Klöppel G
    Virchows Arch; 2007 Aug; 451 Suppl 1():S29-38. PubMed ID: 17684762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future perspectives on neuroendocrine tumors.
    Castellano D; Salazar R; Raymond E
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():35-40. PubMed ID: 21327890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine tumors and tumor syndromes in childhood.
    Gaal J; de Krijger RR
    Pediatr Dev Pathol; 2010; 13(6):427-41. PubMed ID: 19708762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
    Faivre S; Sablin MP; Dreyer C; Raymond E
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
    Minnetti M; Grossman A
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of neuroendocrine tumors.
    Öberg K
    Semin Oncol; 2013 Feb; 40(1):37-44. PubMed ID: 23391111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.